Categories: HealthcareNews

B&D Capital Partners Advises MedShift

CHARLOTTE, N.C.–(BUSINESS WIRE)–B&D Capital Partners is pleased to announce the successful placement of an $89.5 million debt financing led by Huntington Bank and up to $200 million of capital commitments in a special purpose financing vehicle led by Stonehenge Structured Finance Partners and Blystone & Donaldson for MedShift, LLC. The initial transaction closed on October 18, 2024 and the combined $289.5m of total potential funding provides MedShift with access to sufficient capital to support its long term future growth.


This transaction emphasizes Huntington’s highly differentiated strategy of delivering national expertise locally and highlights a successful collaboration between local partners, including Blystone & Donaldson.

MedShift, a medical technology company founded in 2015 and headquartered in Charlotte, North Carolina, is a leader in the healthcare technology industry. The company caters to medical industry manufacturers as well as individual medical practices and providers across various markets, including dermatology, gynecology, plastic surgery, and medspa.

MedShift operates through three technology divisions (digitally automated credit underwriting/contracting, connected medical device, and enterprise SaaS), offering a comprehensive suite of innovative and cutting-edge software and hardware solutions. In addition, MedShift provides a range of complementary products and services, such as device consumables and injectables that streamline the complex supply-and-demand landscape, providing a highly differentiated and value-creating experience for both medical device suppliers and medical providers.

B&D Capital Partners, served as the financial advisor to the company and assisted in arranging, structuring, and negotiating the debt financing. B&D ultimately achieved the company’s objectives through a competitive process which included refinancing existing higher cost indebtedness, providing incremental liquidity to fund device purchases through the SPV, and securing more flexible debt service to allow management greater investment in the future growth of the business.

B&D Capital Partners is an affiliate of Blystone & Donaldson, LLC, a Charlotte, NC based investment firm with expertise and equity investments across several industries. B&D Capital Partners is a FINRA-registered broker-dealer and member of SIPC.

www.finra.org

www.sipc.org

Contacts

Jason Houseman

(716) 989-7708

Jason@bdcappartners.com

Staff

Recent Posts

Restart Life Receives Aggregate Gross Proceeds of Approximately $590,000 from Warrant Exercises and Loan

Vancouver, British Columbia--(Newsfile Corp. - December 22, 2025) - Restart Life Sciences Corp. (CSE: HEAL)…

2 hours ago

FlyteHealth to Expand Direct Access to Obesity Management Medication for Employers

NEW CANAAN, Conn., Dec. 22, 2025 /PRNewswire/ -- FlyteHealth, a national leader in integrated cardio-kidney-metabolic care,…

2 hours ago

10 Days, 10 Ways to Spend FSA (Flexible Spending Account) Funds Before the December 31 Use-It-or-Lose-It Deadline, from FSA Store®

The clock is ticking on 2025 FSA funds, and as the use-it-or-lose-it deadline approaches, FSA…

2 hours ago

TraceLink Wins 2025 Merit Award — Recognized for Healthcare Innovation for the Third Consecutive Year

TraceLink has been named a winner of the 2025 Merit Awards for Healthcare Innovation, marking…

2 hours ago

NUCALM CELEBRATES RECORD-BREAKING DECEMBER WITH OVER 2 BILLION MINUTES USED AND LARGEST LIVE EVENT ACTIVATION EVER

Tony Robbins' "Date with Destiny" Event Drives Unprecedented Engagement with NuCalm TechnologyPALM BEACH, Fla., Dec.…

2 hours ago

Point-of-Care Is Just the Beginning: Doceree 360 Report Maps Three Strategic Imperatives for HCP Engagement Across All Digital Touchpoints

New Annual Report Reveals Opportunity for Pharma Marketers to Reach Physicians Throughout Entire Decision-Making Journey—From Learning…

2 hours ago